cagrilintide semaglutide combination cagrisema phase 3 results 2024 2025 Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Updates in Medicine | CagriSema

Gut Repair Post-Surgery Research also looks at BPC-157 for its potential in promoting the healing of the intestines after surgeries like intestinal resections or bariatric surgery

Another 2013 study noted that BPC-157 may be used as an antidote against NSAIDs [4] and research interest in BPC-157 for this purpose remains strong

Injection appointments are covered under naturopathic benefits and can be direct billed.

Free shipping on US orders over $100

Acute injuries Recent muscle strains, sprains, mild tendon irritation Moderate injuries Tendinopathy, partial tears, joint inflammation Chronic conditions Long-standing tendon issues, chronic joint degeneration, IBD Post-surgical recovery Initiated shortly after surgery based on procedure and healing Gut healing NSAID damage (acute) or chronic conditions like IBD (longer) How BPC-157 Is Taken Subcutaneous Injection For musculoskeletal injuries, subcutaneous injection is preferred administered using a small insulin-type syringe into the subcutaneous fat layer as close to the injury site as practical